Ignite Creation Date:
2025-12-24 @ 10:34 PM
Ignite Modification Date:
2025-12-28 @ 4:04 PM
Study NCT ID:
NCT03526835
Status:
RECRUITING
Last Update Posted:
2025-01-29
First Post:
2018-04-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
Sponsor:
Merus N.V.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
MCLA-158-CL01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None